Nexgard Spectra 1.9 mg (Milbemycin Oxime TABLET (CHEWABLE)) 1.9 MG

NEXGARD SPECTRA 1.9 MG chewable tablets contain milbemycin oxime, a parasiticide for dogs. This medication helps protect against fleas, ticks, heartworm, and intestinal worms. Ideal for pet owners seeking comprehensive parasite control.

Strength

1.9 MG

Manufacturer / TM Owner

BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NEXGARD SPECTRA 1.9 MG chewable tablets are primarily used for the prevention and treatment of flea and tick infestations in dogs. This medication also helps manage heartworm disease and controls common intestinal worms like roundworms and hookworms. Pet owners often use milbemycin oxime to maintain their dog's overall health and well-being by providing broad-spectrum parasite protection.

Side Effects

When administered as directed, NEXGARD SPECTRA 1.9 MG chewable tablets may help reduce flea and tick populations, preventing infestations and related health issues. This medication works by targeting the nervous system of parasites, leading to their paralysis and death. Some dogs may experience mild effects such as vomiting or diarrhea, though these are typically temporary.

Precautions & Warnings

Always consult a veterinarian before administering NEXGARD SPECTRA 1.9 MG chewable tablets to ensure it is suitable for your dog's specific needs. Store the medication in a cool, dry place away from direct sunlight and keep it out of reach of children and other pets. Monitor your dog for any adverse reactions and discontinue use if severe side effects occur.

Avoid Interactions

NEXGARD SPECTRA 1.9 MG chewable tablets may interact with other medications, particularly those metabolized by the liver. It is important to inform your veterinarian about any other medications or supplements your dog is taking. Avoid administering this medication with known CYP inhibitors, as they can affect the metabolism of milbemycin oxime.

Frequently Asked Questions

NEXGARD SPECTRA 1.9 MG chewable tablets are used to prevent and treat flea and tick infestations, manage heartworm disease, and control intestinal worms in dogs.

Administer the chewable tablet directly to your dog as a treat or with food, ensuring they consume the entire dose.

Common side effects may include vomiting, diarrhea, lethargy, and decreased appetite. These effects are usually mild and temporary.

Yes, NEXGARD SPECTRA 1.9 MG chewable tablets can be purchased online from authorized retailers and veterinary pharmacies.

NEXGARD SPECTRA 1.9 MG is generally safe for dogs, but it is important to consult a veterinarian to ensure it is suitable for your dog's specific health condition.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.